Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cell MedX financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$8.5 M
2024-10-29
Revenue
$95.8 K
FY, 2020
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.2K | 95.8K | ||||||||
| Cost of goods sold | 4.1K | 10.2K | 3.2K | 2.0K | ||||||
| Gross profit | 2.2K | 85.6K | 3.5K | 4.0K | 483.0 | |||||
| Gross profit margin, % | 34.9% | 89.3% | ||||||||
| General and administrative expense | 8.7K | 400.3K | 235.3K | 144.8K | 396.2K | 185.8K | 334.2K | 275.5K | 160.9K | 213.5K |
| Operating expense total | 8.7K | 1.2M | 1.5M | 406.7K | 789.4K | 484.9K | 364.8K | 160.9K | 213.5K | |
| Depreciation and amortization | 580.0 | 1.8K | 2.4K | |||||||
| Interest expense | 29.1K | 11.2K | 25.7K | 47.4K | 61.7K | |||||
| Net Income | (15.9K) | (1.2M) | (1.5M) | (906.0K) | (1.1M) | (910.8K) | (697.4K) | (495.0K) | (142.5K) | (566.3K) |